Makale detayı · 2012 · book-chapter
Vasoactive Intestinal Peptide Enhances Striatal Plasticity and Prevents Dopaminergic Cell Loss in Parkinsonian Rats
ISSN0895-8696
YÖKSİS
OpenAlex
Yıl2012
Atıf22OpenAlex
Atıf22Semantic Scholar · 1 etkili
Yüzdelik%73,3
FWCI0,741,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q2
Veri kaynağı ayrımı
- YÖKSİSYÖKSİS makale kaydı
- YÖKSİS dergi adıJournal of Molecular Neuroscience
- Katalog eşleşmesi (ISSN)Journal of Molecular Neuroscience
- OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
- Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)
Özet
Özet henüz derlenmedi; DergiPark / OpenAlex kuyruğu işlenince burada görünecek.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
22atıfOpenAlex · cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 14 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- 2019 Vasoactive Intestinal Peptide Decreases β-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer’s DiseaseAtıf 31 · OpenAlex
- 2018 Vasoactive Intestinal Peptide Decreases β-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer’s DiseaseAtıf 31 · OpenAlex
- 2016 Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide VIP in Parkinsonian RatsAtıf 26 · OpenAlex
- 2016 Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide VIP in Parkinsonian RatsAtıf 26 · OpenAlex
- 2016 Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide VIP in Parkinsonian RatsAtıf 26 · OpenAlex
- 2016 Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide VIP in Parkinsonian RatsAtıf 26 · OpenAlex
- 2016 Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian RatsAtıf 26 · OpenAlex
- 2019 Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson’s DiseaseAtıf 25 · OpenAlex
- 2019 Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson’s DiseaseAtıf 25 · OpenAlex
- 2021 Vasoactive intestinal peptide (VIP) conducts the neuronal activity during absence seizures: GABA seems to be the main mediator of VIPAtıf 7 · OpenAlex